INTERNATIONAL PATENT: MERCK SHARP & DOHME LLC FILES APPLICATION FOR "COMBINATION THERAPY OF A PD-1 ANTAGONIST AND LAG3 ANTAGONIST AND ALL-TRANS RETINOIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING PATIENTS WITH CANCER"

GENEVA, June 25 -- MERCK SHARP & DOHME LLC (126 East Lincoln AvenueRahway, New Jersey 07065) filed a patent application (PCT/US2024/059278) for "COMBINATION THERAPY OF A PD-1 ANTAGONIST AND LAG3 ANTAGONIST AND ALL-TRANS RETINOIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING PATIENTS WITH CANCER" on Dec 10, 2024. With publication no. WO/2025/128499, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DIEDE, Scott J. (126 East Lincoln AvenueRahway, New Jersey 07065), DUIC, Julius Paul (126 East Lincoln AvenueR...